JDRF is continually striving to improve the lives of people with type 1 diabetes, with the ultimate goal of delivering a cure for type 1 diabetes and its complications.
JDRF's research strategy focuses on curing, treating and preventing type 1 diabetes.
For those who have been diagnosed with type 1 diabetes, replacing or renewing insulin-producing cells, and also stopping the body from attacking these cells. Read more.
For those who are living with type 1 diabetes, the creation of new devices and therapies to optimise glucose control and better manage and prevent the complications of diabetes. Read more.
For those who are at risk of developing type 1 diabetes or are at the very early stages of disease progression, creating a viable vaccine or therapy to prevent the disease. Read more.
While clear progress is being made towards a cure for type 1 diabetes, we recognise that delivering it will be a marathon effort, rather than a sprint. That is why we are also committed to keeping people healthy with better treatments for type 1 diabetes, and preventing it from developing in those at risk of developing the disease.
JDRF is involved with all parts of the research pipeline.
In addition to focusing on research that will lead to curing, better treating and preventing type 1 diabetes, we are working on removing the barriers that prevent research breakthroughs from becoming new technologies and therapies for people with type 1 diabetes.
We help to translate research from the laboratory into accessible treatments through increased support for clinical research through the Australian Type 1 Diabetes Clinical Research Network.
We work with a range of partners to drive research progress and delivering it to those who can benefit. These include relationships with other diabetes organisations, industry partners, academia, clinicians, regulatory agencies, Government and healthcare payers.
We are the only organisation with the scale, expertise and relationships required to translate research from the laboratory into life-changing outcomes for people with type 1 diabetes – and we are making progress.
To read more about the latest research, visit the JDRF blog.